CSRLF yields 4.00% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, CSRLF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CSRLF + JNJ for your $10,000?
CSR Limited, together with its subsidiaries, engages in the manufacture and supply of building products for residential and commercial constructions in Australia and New Zealand. It operates through Building Products, Property, and Aluminium segments. The Building Products segment offers interior systems, including gyprock plasterboards, Martini acoustic insulation products, and Rondo rolled formed steel products, as well as Himmel and Potter interior systems that supplies ceiling tiles, aluminum partitions, and architectural hardware products; construction systems, such as Hebel autoclaved aerated concrete products, AFS walling systems, cladding systems, and Cemintel fiber cement; masonry and insulation solutions comprising Bradford insulations, Bradford energy solutions, Edmonds ventilation systems, and Monier roofing solutions; and bricks, including PGH Bricks and pavers. The company's Property segment sells former operating sites. This segment is also involved in the large-scale developments in New South Wales, Queensland, and Victoria. Its Aluminium segment offers aluminium ingots, billets, and slabs. CSR Limited was founded in 1855 and is headquartered in North Ryde, Australia.
Full CSRLF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.